Abbott (ABT) Director Kevin T. Conroy Surrenders 52,507 Shares for Taxes

What Happened
Kevin T. Conroy, a director of Abbott Laboratories (ABT), had 52,507 shares disposed on Sept 23, 2026 to satisfy tax withholding related to an equity award or option event. The shares were valued at $103.99 each, for a total value of approximately $5,460,203. This was a tax-withholding/net-settlement action (not an open-market sale).

Key Details

• Transaction date: 2026-09-23; Filing date: 2026-09-25 (filed within the typical two-business-day Form 4 window).
• Price per share: $103.99; Total value of shares withheld: ~$5,460,203.
• Transaction code: F — “Payment of exercise price or tax liability” (shares were surrendered/withheld to cover taxes).
• Shares owned after the transaction: Not specified in the provided filing summary.
• Disposition type: Shares were withheld/cancelled to satisfy tax obligations (a net settlement), not an open-market sale.

Context
This is a routine tax-withholding action tied to the vesting/exercise of equity (a common administrative step). Such withholdings are not generally interpreted as a directional trading signal like open-market purchases or sales. Purchases by insiders tend to be more informative about insider sentiment than tax-withholding disposals.